Antiretroviral treatment sequencing strategies to overcome HIV type 1 drug resistance in adolescents and adults in low-middle-income countries

Antiretroviral treatment sequencing strategies to overcome HIV type 1 drug resistance in adolescents and adults in low-middle-income countries

Item
http://www.wikidata.org/entity/Q27001286
Durability of antiretroviral therapy and predictors of virologic failure among perinatally HIV-infected children in Tanzania: a four-year follow-up.HIV type 1 drug resistance patterns among patients failing first and second line antiretroviral therapy in Nairobi, KenyaCross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq.Implementation and Operational Research: Correlates of Adherence and Treatment Failure Among Kenyan Patients on Long-term Highly Active Antiretroviral TherapyHemaSpot, a Novel Blood Storage Device for HIV-1 Drug Resistance Testing.Treatment failure and drug resistance in HIV-positive patients on tenofovir-based first-line antiretroviral therapy in western KenyaLong-term effectiveness of initiating non-nucleoside reverse transcriptase inhibitor- versus ritonavir-boosted protease inhibitor-based antiretroviral therapy: implications for first-line therapy choice in resource-limited settings.Implementing HIV-1 genotypic resistance testing in antiretroviral therapy programs in Africa: needs, opportunities, and challenges.Phenotypic and genotypic analyses to guide selection of reverse transcriptase inhibitors in second-line HIV therapy following extended virological failure in Uganda.Virological failure after 1 year of first-line ART is not associated with HIV minority drug resistance in rural Cameroon .Accumulation of HIV-1 drug resistance in patients on a standard thymidine analogue-based first line antiretroviral therapy after virological failure: implications for the activity of next-line regimens from a longitudinal study in Mozambique.Interplay Between Transmitted and Acquired HIV Type 1 Drug Resistance: Reasons for a Disconnect.
P2860

Antiretroviral treatment sequencing strategies to overcome HIV type 1 drug resistance in adolescents and adults in low-middle-income countries

Item
http://www.wikidata.org/entity/Q27001286
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Antiretroviral treatment seque ...... in low-middle-income countries
@ast
Antiretroviral treatment seque ...... in low-middle-income countries
@en
Antiretroviral treatment seque ...... in low-middle-income countries
@nl
type
label
Antiretroviral treatment seque ...... in low-middle-income countries
@ast
Antiretroviral treatment seque ...... in low-middle-income countries
@en
Antiretroviral treatment seque ...... in low-middle-income countries
@nl
prefLabel
Antiretroviral treatment seque ...... in low-middle-income countries
@ast
Antiretroviral treatment seque ...... in low-middle-income countries
@en
Antiretroviral treatment seque ...... in low-middle-income countries
@nl
P1433
P1476
P2093
P2860
P304
P31
P3181
P356
P407
P478
P577
P5875
P698
P921
P3181
P356
P1433
P1476
Antiretroviral treatment seque ...... in low-middle-income countries
@en
P2093
P2860
P304
P31
P3181
P356
P407
P478
P577
P5875
P698
P921